Glims M Tablet
Glimepiride + Metformin
              1 mg+500 mg  
              
              Opsonin Pharma Limited
                  
              
              | Pack size | 30's pack | 
|---|---|
| Unite Price | 9.00 BDT | 
Indications
Glims M Tablet is used for: 
 Type 2 diabetes mellitus
                                              
                        Adult Dose
Oral
Type 2 diabetes mellitus
Adult:  Each tablet contains glimepiride 1 mg or 2 mg and metformin sustained release 500 mg
The  initial  recommended  dose  is  one  tablet  once  daily  
Maximum Recommended Dose
The  maximum  recommended  dose  for  glimepiride is  8  mg  daily.  The  maximum recommended daily dose for metformin sustained-release is 2000 mg in adults.
Dosage  should  be  individualized  on  the  basis  of  both  effectiveness and tolerance. 
                                              
                        Child Dose
Renal Dose
Administration
Should be taken with breakfast  or  first main meal of the day. 
                                              
                        Contra Indications
Renal disease or renal dysfunction, as suggested by serum creatinine levels ≥1.5 mg/dL  [males],  
≥1.4  mg/dL  [females]  or  abnormal creatinine  clearance,  which  may  also  result  from  conditions  such  as cardiovascular  collapse  (shock),  acute  myocardial infarction, and septicaemia.
Hepatic impairment.
Known hypersensitivity to this product or any of its components.
Acute  or  chronic  metabolic  acidosis,  including  diabetic  ketoacidosis,  with or without coma. Diabetic ketoacidosis should be treated with insulin.
Patients  undergoing  radiologic  studies  involving  intravascular administration  of  iodinated  contrast  materials,  because  the use of  such products  may  result  in  acute alteration of renal function
Pregnancy, lactation.
                                              
                        Precautions
Renal and hepatic impairment. Avoid alcohol consumption. Hypoglycaemic episodes.
                                              
                        Pregnancy-Lactation
Interactions
Cationic  drugs:  Certain  medications  used  concomitantly  with  metformin  may increase  the  risk  of  lactic  acidosis.  Cationic  drugs  that  are  eliminated  by  renal tubular  secretions  (e.g:  amiloride,  digoxin,  morphine,  procainamide,  quinidine, ranitidine,  or  vancomycin)  may  decrease  metformin  elimination  by  competing  for  common  renal  tubular  transport  systems.  Hence,  careful  patient  monitoring  and  dose adjustment of metformin/cationic drug is recommended. 
Miconazole  (systemic  route,  oromucosal  gel)  and  Phenylbutazone (systemic route): 
Increases hypoglycemic effect of glimepiride.
Thiazide: 
Interactions  between  thiazide  diuretics  and  oral  antidiabetic  agents decreases   insulin   sensitivity   thereby   leading   to   glucose   intolerance   and hyperglycemia. Hence diabetic patients should be monitored closely.
Other: 
Concomitant  administration  of  angiotensin  enzyme  inhibitors  (captopril, enalapril),  other  antidiabetic  drugs  (insulin,  acarbose)  beta-blockers,  fluconozole, monoamine  oxidase  inhibitors  (MAOIs),  sulphonamides  and NSAIDs, increasessensitivity to insulin and potentiates blood glucose lowering effect and may in  some 6 instances, cause hypoglycemia. Patients receiving estrogens or oral contraceptives, phenytoin, quinolones should be closely monitored for loss of  diabetic control.
Potentially Fatal: NSAIDS, salicylates, sulfonamides, chloramphenicol, coumarins, probenecid, MAOs, and beta blockers potentiate the hypoglycemic action of glimepiride.
                                              
                        Side Effects
Side effects of Glimepiride + Metformin : 
 Diarrhoea,  vomiting,  metallic taste,  rash,  isolated transaminase elevations,  cholestatic jaundice,  allergic skin reactions,  photosensitivity reactions,  leukopaenia,  agranulocytosis,  thrombocytopaenia,  haemolytic anaemia,  aplastic anaemia,  pancytopaenia,  blurred vision.
Potentially Fatal: Lactic acidosis.
                                              
                        Mode of Action
Glimepiride stimulates the insulin release from functioning pancreatic β-cells and inhibits gluconeogenesis at hepatic cells. It also increases insulin sensitivity at peripheral target sites. 
Metformin decreases hepatic gluconeogenesis, decreases intestinal absorption of glucose and improves insulin sensitivity (increases peripheral glucose uptake and utilisation).
                                              
                        Note
Glims M 1 mg+500 mg Tablet generic name is Glimepiride + Metformin. Glims M 1 mg+500 mg Tablet is manufactured by Opsonin Pharma LimitedGlims M is availble in all over Bangladesh.
 Mes BD drug index information on Glims M Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.